Taysha Gene Therapies Announces Progress Across TSHA-102 Pivotal Gene Therapy Program in ...

First patient dosed in REVEAL pivotal trial evaluating TSHA-102 (N=15, aged 6 to <22 years) in Q4 2025, with enrollment ...

WiMi Achieves Coexistence of Lightweight Design and High Performance by Efficiently ...

WiMi Hologram Cloud Inc. (NASDAQ: WiMi) focuses on holographic cloud services, primarily concentrating on professional fields such as in-vehicle AR holographic HUD, 3D holographic pulse LiDAR, ...

WiMi Releases Next-Generation Quantum Convolutional Neural Network Technology for Multi ...

WiMi Releases Next-Generation Quantum Convolutional Neural Network Technology for Multi-Channel Supervised Learning BEIJING, Jan. 05, 2026––WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the ...